Immunoprotective determinants in friend murine leukemia virus envelope protein

Virology

Volumn 248, Issue 1, 1998, Pages 66-73

  Hasenkrug, Kim J ^a   Brooks, Diane M ^a   Robertson, Michael N ^b   Srinivas, R V ^c   Chesebro, Bruce ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c Glass Tower   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; VIRUS VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FRIEND LEUKEMIA VIRUS; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; VACCINATION; VIREMIA; VIRUS REPLICATION;

EID: 0032529674     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9264     Document Type: Article

References (44)

1. Bangham C. R., Phillips R. E. What is required of an HIV vaccine. Lancet. 350:1997;1617-1621.
2. Bolognesi D. P. Overview of HIV vaccine development. The Immune response to HIV: Implications for vaccine development. Antibiot. Chemother. 48:1996;63-67.
3. Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B., Shaw G. M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virusvirus [see comments]. Nat. Med. 3:1997;205-211.
4. Britt W. J., Chesebro B. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia. J. Immunol. 130:1983;2363-2367.
5. Cease K. B., Berzofsky J. A. Toward a vaccine for AIDS: The emergence of immunobiology-based vaccine development. Annu. Rev. Immunol. 12:1994;923-989.
6. Chesebro B., Bloom M., Wehrly K., Nishio J. Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia. J. Virol. 32:1979;832-837.
7. Chesebro B., Miyazawa M., Britt W. J. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8:1990;477-499.
8. Chesebro B., Wehrly K. Identification of anon-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA. 76:1979;425-429.
9. Chesebro B., Wehrly K., Cloyd M., Britt W., Protis J., Collins J., Nishio J. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology. 112:1981;131-144.
10. Chesebro B., Wehrly K., Stimpfling J. Host genetic control of recovery from Friend leukemia virus-induced splenomegaly. Mapping of a gene within the major histocompatibility complex. J. Exp. Med. 140:1974;1457-1467.
11. Coffin J. M. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy [see comments]. Science. 267:1995;483-489.
12. Daniel M. D., Mazzara G. P., Simon M. A., Sehgal P. K., Kodama T., Panicali D. L., Desrosiers R. C. High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res. Hum. Retroviruses. 10:1994;839-851.
13. Earl P. L., Moss B., Mossiron R. P., Wehrly K., Nishio J., Chesebro B. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirusenv. Science. 234:1986;728-731.
14. Giavedoni L. D., Planelles V., Haigwood N. L., Ahmad S., Kluge J. D., Marthas M. L., Gardner M. D., Luciw P. A., Yilma T. D. Immune response of Rhesus macaques to recombinant Simian Immunodeficiency Virus gp130 does not protect from challenge infection. J. Virol. 67:1993;577-583.
15. Goulder P. J., Phillips R. E., Colbert R. A., McAdam S., Ogg G., Nowak M. A., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A. J., Rowland-Jones S. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:1997;212-217.
16. Hasenkrug K. J., Brooks D. M., Chesebro B. Passive immunotherapy for retroviral disease: Influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. USA. 92:1995;10492-10495.
17. Hasenkrug K. J., Brooks D. M., Nishio J., Chesebro B. Differing T-cell requirements for recombinant retrovirus vaccines. J. Virol. 70:1996;368-372.
18. Hasenkrug K. J., Chesebro B. Immunity to retroviral infection: The Friend virus model. Proc. Natl. Acad. Sci. USA. 94:1997;7811-7816.
19. Hoatlin M. E., Kabat D. Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol. 3:1995;51-57.
20. Hunsmann G., Schneider J., Schulz A. Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology. 113:1981;603-612.
21. Ishihara C., Miyazawa M., Nishio J., Azuma I., Chesebro B. Use of low toxicity adjuvants and killed virus to induce protective immunity against the Friend murine leukaemia retrovirus-induced disease. Vaccine. 10:1992;353-356.
22. Iwashiro M., Kondo T., Shimizu T., Yamagishi H., Takahashi K., Matsubayashi Y., Masuda T., Otaka A., Fujii N., Ishimoto A., Miyazawa M., Robertson M. J., Chesebro B., Kuribayashi K. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J. Virol. 67:1993;4533-4542.
23. Kleiser C. J., Schneider J., Bayer H., Hunsmann G. Immunoprevention of Friend leukaemia virus-induced erythroleukaemia by vaccination with aggregated gp70. J. Gen. Virol. 67:1986;1901-1907.
24. Koch W., Zimmermann W., Oliff A., Friedrich R. Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: Implications for the functions of these sequences. J. Virol. 49:1984;828-840.
25. Lander M. R., Chattopadhyay S. K. AMus dunni. J. Virol. 45:1984;695-698.
26. Li J.-P., D'Andrea A. D., Lodish H. F., Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (London). 343:1990;762-764.
27. McCune J. M. Viral latency in HIV disease. Cell. 82:1995;183-188.
28. Miyazawa M., Fujisawa R., ishihara C., Takei Y. A., Shimizu T., Uenishi H., Yamagishi H., Kuribayashi K. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. J. Immunol. 155:1995;748-758.
29. Miyazawa, M. Nishio, J. Chesebro, B. 1990, Partial protection of susceptible mice against Friend retrovirus-induced leukemia with vaccinia-Friendgag, In, Vaccines 90: Modern Approaches to New Vaccines Including Prevention of AIDS, 407, 412, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
30. Miyazawa M., Nishio J., Chesebro B. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. J. Virol. 66:1992;4497-4507.
31. Morrison R. P., Earl P. L., Nishio J., Lodmell D. L., Moss B., Chesebro B. Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (London). 329:1987;729-732.
32. Nowak M. A., May R. M., Phillips R. E., Rowland-Jones S., Lalloo D. G., McAdam S., Klenerman P., Koppe B., Sigmund K., Bangham C. R., McMichael A. J. Antigenic oscillations and shifting immunodominance in HIV-1 infections [see comments]. Nature. 375:1995;606-611.
33. Oliff A., Collins L., Mirenda C. Molecular cloning of Friend mink cell focus-inducing virus: Identification of mink cell focus-inducing virus-like messages in normal and transformed cells. J. Virol. 48:1983;542-546.
34. Oliff A. I., Linemeyer D., Ruscetti S., Lowe R., Lowy D. R., Scolnick E. M. Subgenomic fragment of molecularly cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease. J. Virol. 35:1980;924-936.
35. Phillips R. E., Rowland-Jones S., Nixon D. F., Gotch F. M., Edwards J. P., Ogunlesi A. O., Elvin J. G., Rothbard J. A., Bangham C. R., Rizza C. R., McMichael A. J. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition [see comments]. Nature. 354:1991;453-459.
36. Polsky D., Lilly F. Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype. Proc. Natl. Acad. Sci. USA. 88:1991;9243-9247.
37. Price D. A., Goulder P. J., Klenerman P., Sewell A. K., Easterbrook P. J., Troop M., Bangham C. R., Phillips R. E. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA. 94:1997;1890-1895.
38. Robertson M. N., Miyazawa M., Mori S., Caughey B., Evans L. H., Hayes S. F., Chesebro B. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: Use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J. Virol. Methods. 34:1991;255-271.
39. Robertson M. N., Spangrude G. J., Hasenkrug K., Perry L., Nishio J., Wehrly K., Chesebro B. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J. Virol. 66:1992;3271-3277.
40. Ruan K. S., Lilly F. Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes [published erratum appears in Virology 1991 Jun;182(2):894]. Virology. 181:1991;91-100.
41. Ruan K. S., Lilly F. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA. 89:1992;12202-12206.
42. Shimizu T., Uenishi H., Teramura Y., Iwashiro M., Kuribayashi K., Tamamura H., Fujii N., Yamagishi H. Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells. J. Virol. 68:1994;7704-7708.
43. Sitbon M., Nishio J., Wehrly K., Lodmell D., Chesebro B. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: Distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology. 141:1985;110-118.
44. Wendling F., Moreau-Gachelin F., Tambourin P. Emergence of tumorigenic cells during the course of Friend virus leukemias. Proc. Natl. Acad. Sci. USA. 78:1981;3614-3618.